All

Gilbert to kick off 2026 Series A Investment Roadshow in Basel at the Health.Tech Global Summit, March 3-5.

Following on from last November’s successful LSX Investival Showcase event in London, UK, Gilbert will present its Series A funding round at Health.tech Global Summit in Basel, CH, the premier event bringing together the people that are shaping the future of healthcare.
Looking to raise €10 million equity investment to fuel our path to commercial stage of the company, Gilbert will continue its Roadshow with presentations at Health Holland’s Global Investment Forum in Utrecht, NL, March 25-26 and the MedTech Strategist Innovation Summit in Dublin, IRL, April 28-30.
Come meet our CEO Maurits Huigen to explore how you can join our consortium of investors to revolutionize healthcare and make impact for patients, health systems, society and the environment with the next generation of inhaled therapies.

health.tech｜global summit • 3–5 March 2026 • Basel

Health~Holland Global Investor Forum | Lifesciences @ Work

Innovation Summit Dublin 2026 | MedTech Strategist — MedTech Strategist

This years Pulmonary Drug Delivery Conference (PDD2025) will take place in Istanbul from Wednesday June 11th – Friday June 13th. PDD connects academia and industry leaders and brings together participants from Western and Eastern Europe as well as Asia and Africa to discuss developments with inhalation drugs.

We are excited to announce that our Chief Scientific & Technology Officer Dr. Mehmet Üzümcü will be presenting at the conference on June 11th. The title of the presentation is: ‘Facilitating a High and Targeted Lung Dose by Electrohydrodynamic Atomization in a Smart Precision Inhaler’.

In his presentation, Dr. Üzümcü will elaborate on the importance of targeted drug delivery to the lungs and the relevance of a tuneable and monodisperse droplet size and size distribution. Furthermore, he will explain how Gilbert can achieve this in their disruptive smart inhaler device based on the proprietary electrospray technology. 

To plan a meeting at the conference or if you are interested to learn more about this presentation, please contact us at info@Gilbert.eu or reach out directly to Dr. Mehmet Üzümcü.

Gilbert is proud to be featured in a publication of Brainport Eindhoven, titled ‘Innovation and Impact in Inhalation Therapy from the Heart of the Brainport Region’, being one of the MedTech Pioneers in the Brainport region. CEO Maurits Huigen and CCO Scott Fleming share their vision on the company and its Smart Precision Inhaler.

The article describes the university roots of the company and explains the potential of our disruptive, proprietary electrospray technology based, inhaler device and wide set of applications. Gilbert is proud and grateful to be part of the Brainport ecosystem, which has been instrumental to the success of the company so far.

The full article can be found here.

We’re privileged to announce that we’ve been selected as one of the esteemed Hello Tomorrow Deep Tech Pioneers. Out of thousands of applications, our Smart Precision Inhaler solution stood out to their experts, and we couldn’t be more excited!

Dutch deep-tech investor DeepTechXL is truly excited that Gilbert, one of DeepTechXL’s disruptive technology portfolio companies, has been selected out of thousands of applicants by Hello Tomorrow. This reward underpins the novelty of Gilbert’s proprietary smart precision inhaler and emphasizes its potential to have a positive societal impact with improved drug delivery and therapy adherence for millions of patients.

Join us at the 10th Hello Tomorrow Global Summit in Paris on March 13-14, 2025, and connect with the world’s top innovators, industry leaders, investors, and deep tech visionaries.

Let’s shape the future of deep tech together to redefine treatment for lung patients!

Don’t miss out! 👉Global Summit – Hello Tomorrow

Gilbert looks forward to attending the annual DDL (Drug Delivery to the Lungs) conference in Edinburgh from Dec 11th-13th.

This year DDL is celebrating its 35th anniversary and this promises to be a landmark event attracting over 1000 scientists, academics, clinicians, regulators and industry experts worldwide, all with a focus on improving pulmonary drug delivery for serious lung diseases.

As we are working hard on the development of our Smart Precision Inhaler, we are especially looking forward to the session on Gene Therapy & Biologics for the Lungs and to explore how we can enable and improve the delivery of these important advances in treatment.

With mono-dispersed and customizable aerosol generation, we believe that Gilbert’s electrospray soft mist inhaler may hold significant promise for improved targeting and delivery of these innovative medicines.

Let’s redefine treatment for lung patients together!

So if you are also joining, let’s meet up in Edinburgh!

To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Scott Fleming, Mehmet Üzümcü or Maurits Huigen who will all be there.

The Gilbert team looks forward to attending the International Conference on “Exploring the Future of Inhalation Drug Delivery“, organized by the University of Parma and supported by the Galenus Foundation, in Parma, Italy from Sept 11th-13th.

As we are working hard on the development of our Smart Precision Inhaler, we look forward to connecting with professionals working on improvements in formulation and development of inhaled medicine.

With customizable aerosol generation, we believe that Gilbert’s electrospray soft mist inhaler may hold significant promise for the delivery of the innovative medicines under research today.

Let’s redefine treatment for lung patients together!

So if you are also visiting, let’s meet up in Parma!

To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Mehmet Üzümcü, Scott Fleming or Fatemeh Jahanmard who will be visiting the conference.